Related Content
April 8, 2019 โ TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for ...
November 9, 2017 โ TherOx Inc. announced that results of its IC-HOT (Evaluation of Intracoronary Hyperoxemic Oxygen ...
September 29, 2017 โ TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the premarket ...
May 19, 2017 โ TherOx Inc. announced that it completed enrollment in the IC-HOT (Evaluation of Intracoronary Hyperoxemic ...
February 22, 2016 โ TherOx Inc. announced the first patient has been enrolled in an Investigational Device Exemption ...
November 10, 2015 โ TherOx Inc. announced it has received U.S. Food and Drug Administration (FDA) Investigational Device ...
December 12, 2013 โ TherOx Inc. released results from the company's multicenter investigational device exemption (IDE) ...
October 15, 2013 โ TherOx Inc., a medical device company focused on the treatment of Acute Myocardial Infarction (AMI) ...
March 20, 2013 โ TherOx Inc. announced the initiation of its multicenter investigational device exemption (IDE) pilot ...
October 30, 2007) โ TherOx Inc., a privately held medical device company, announced it has met its endpoints for its ...